Prognostic impact of serum transthyretin in patients with non-small cell lung cancer.

Shimura, Tatsuo; Shibata, Masahiko; Inoue, Takuya; Owada-Ozaki, Yuki; Yamaura, Takumi; Muto, Satoshi; Hasegawa, Takeo; Shio, Yutaka; Suzuki, Hiroyuki

Shimura, Tatsuo; Shibata, Masahiko; Inoue, Takuya; Owada-Ozaki, Yuki; Yamaura, Takumi; Muto, Satoshi; Hasegawa, Takeo; Shio, Yutaka; Suzuki, Hiroyuki.

Afiliación

Shimura T; Department of Progressive DOHaD Research, Fukushima Medical University, Fukushima 960-1295, Japan.
Shibata M; Department of Advanced Cancer Immunotherapy, Fukushima Medical University, Fukushima 960-1295, Japan.
Inoue T; Department of Chest Surgery, Fukushima Medical University, Fukushima 960-1295, Japan.
Owada-Ozaki Y; Department of Chest Surgery, Fukushima Medical University, Fukushima 960-1295, Japan.
Yamaura T; Department of Chest Surgery, Fukushima Medical University, Fukushima 960-1295, Japan.
Muto S; Department of Chest Surgery, Fukushima Medical University, Fukushima 960-1295, Japan.
Hasegawa T; Department of Chest Surgery, Fukushima Medical University, Fukushima 960-1295, Japan.
Shio Y; Department of Chest Surgery, Fukushima Medical University, Fukushima 960-1295, Japan.
Suzuki H; Department of Chest Surgery, Fukushima Medical University, Fukushima 960-1295, Japan.

Mol Clin Oncol ; 10(6): 597-604, 2019 Jun.

Article en En | MEDLINE | ID: mdl-31031974

Palabras clave

malnutrition; non-small cell lung cancer; prealbumin; prognosis; transthyretin

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Mol Clin Oncol Año: 2019 Tipo del documento: Article País de afiliación: Japón

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google